IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-γ production by NK cells

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 941-947

  Kawakami, Kazuyoshi ^a   Koguchi, Yoshinobu ^a   Qureshi, Mahboob Hossain ^a,e   Miyazato, Akiko ^a   Yara, Satomi ^a   Kinjo, Yuki ^a   Iwakura, Yoichiro ^b   Takeda, Kiyoshi ^c   Akira, Shizuo ^c   Kurimoto, Masashi ^d   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; INTERLEUKIN 12; INTERLEUKIN 18; NEUTRALIZING ANTIBODY; PROTEIN P40;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; FEMALE; FUNGUS GROWTH; GENE DISRUPTION; HOST RESISTANCE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL;

EID: 0034662234     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.941     Document Type: Article

References (45)

1. Stevens, D. A. 1990. Fungal infections in AIDS patients. Br. J. Clin. Practice 44(Suppl. 1):11.
2. Diamond, R. D. 1995. Cryptococcus neoformans. In Principles and Practice of Infectious Diseases. G. L. Mandell, J. E. Bennett and R. Dollin, eds. Churchill Livingstone, New York, p. 2331.
3. Lim, T. S., and J. W. Murphy. 1980. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect. Immun. 30:5.
4. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1472.
5. + T cells. J. Exp. Med. 173:793.
6. + T cells. J. Exp. Med. 173:755.
7. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
8. Granger, D. L., J. B. Hibbs, Jr., J. R. Prefect, and D. T. Durack. 1988. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Invest. 81:1129.
9. Tohyama, M., K. Kawakami, M. Futenma, and A. Saito. 1996. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide. Clin. Exp. Immunol. 103:436.
10. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol. Today 17:138.
11. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
12. Gazzmelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinichieri, and A. Sher 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533.
13. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and CB-17 mice. J. Immunol. 152:1883.
14. Rpmani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Pucetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 152:5167.
15. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 response. Eur J. Immunol. 26:1553.
16. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39.
17. Decken, K., G. Kohler, K. Palmer-Lehmann, A. Wunderlin, F. Mattner, J. Magram, M. K. Gately, and G. Alber. 1998. Interleukin-12 is essential for a protective ThI response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:4994.
18. Clemons, K. V., E. Brummer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460.
19. Kawakami, K., M. Tohyama, Q. Xie, and A. Saito. 1996. Interleukin-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104:208.
20. Kawakami, K., M. Tohyama, Q. Xie, and A. Saito. 1997. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65:1307.
21. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88.
22. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity. 7:571.
23. Bohn, E., A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, and I. B. Autenrieth. 1998. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol 160:299.
24. Mastroeni, P., S. Clare, S. Khan, J. A. Harrison C. E. Hormaeche, H. Okamura, M. Kurimoto, and G. Dougan. 1999. Interleukin 18 contributes to host resistance and γ Interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67:478.
25. Fujioka, N., R. Akazawa, K. Ohashi, M. Fujii, M. Ikeda, and M. Kurimoto. 1999, Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J. Virol. 73:2401.
26. Wei, X., B. P. Leung, W. Niedbala, D. Piedrfita, G. Feng, M. Sweet, L. Dobbie, A. J. H. Smith, and F. Y. Liew. 1999. Altered immune responses and susceptibility to Listeria major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163:2821.
27. Kawakami, K., M. H. Qureshi, T. Zhang, H. Okamura, M. Kurimoto, and A. Saito. 1997. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. J. Immunol. 159: 5528.
28. Zhang, T., K. Kawakami, M. H. Qureshi, H. Okamura, M. Kurimoto, and A. Saito. 1997. Interleukin (IL)-12 and IL-18 synergistitally induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of interferon-γ by natural killer cells. Infect. Immun. 65:3594.
29. Qureshi, M. H., T. Zhang, Y. Koguchi, K. Nakajima, H. Okamura, M. Kurimoto, and K. Kawakami. 1999. Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. Eur. J. Immunol. 29:643.
30. -/- mice: role for IFN-γ in activating apoptosis of hepatocytes. J. Immunol. 159:1418.
31. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K, Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.
32. Yasuoka, A., S. Kohno, H. Yamada, M. Kaku, and H. Koga. 1994. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis. Microbiol. Immunol. 38:851.
33. Kawakami, K., S. Kohno, N. Morikawa, J. Kadota, A. Saito, and K. Hara. 1994. Activation of macrophages and expansion of specific T lymphocytes in the lungs of mice intratracheally inoculated with Cryptococcus neofomans. Clin. Exp. Immunol. 96:230.
34. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulating factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
35. Hunter, C. A., C. Subauste, V. H. van Cleave, and J. S. Remington. 1994. Production of γ interferon by natural killer cells from Toxiplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 62:2818.
36. Skeen, M. J., and H. K. Ziegler. 1995. Activation of 78 T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J. Immunol. 154:5832.
37. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4:471.
38. Yoshimoto, T., H. Okamura, Y. Tagawa, Y. Iwakura, and K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. USA 94:3948.
39. Munder, M., M. Mallo, K. Eichmann, and M. Modolell. 1998. Murine macrophages secrete interferon y upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187:2103.
40. Okamura, H., H. Tsutsui, S. Kashiwamura, T. Yoshimoto, and K. Nakanishi. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:281.
41. Dinarello, C. A. 1999 IL-18: a Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103:11.
42. Stoll S., H. Jonuleit, E. Schmitt, O. Muller, H. Yamauchi, M. Kurimoto, J. Knop, and A. H. Enk. 1998. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 28:3231.
43. Dunn, P. L., and R. J. North. 1991. Early γ interferon production by natural killer cells is important in defense against murine listeriosis. Infect. Immun. 59:2892.
44. Laskay, T., M. Rolinghoff, and W. Solbach. 1993. Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 23:2237.
45. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567.